NFKB1 and thyroid cancer: Bauerle and co-workers have used the NF-κB inhibitors Bay-11-7082, IKK inhibitor VII, and CDDO-Me in advanced thyroid cancer cell lines and found that only one cell line shows a significant decrease in cell growth [89].